Association between Psoriasis Area and Severity Index Score and atherosclerotic risk in psoriasis patients using the

Airi Kobayashi1, Hitoshi Terui1, Ryoko Shimada-Omori1

  • 1Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Immunological Medicine
|March 17, 2026
PubMed

Insights

Psoriasis severity, measured by the Psoriasis Area and Severity Index (PASI), is linked to higher cardiovascular disease risk in Japanese adults. The Hisayama Score can help assess this risk, especially in men with high PASI scores.

Area of Science:

  • Dermatology
  • Cardiology
  • Public Health

Background:

  • Psoriasis is a chronic inflammatory skin condition associated with increased cardiovascular disease (CVD) risk.
  • The Hisayama Score is a validated tool for assessing cardiovascular and stroke risk in Japan.

Purpose of the Study:

  • To investigate the association between psoriasis severity (PASI) and cardiovascular risk using the Hisayama Score in a Japanese population.
  • To evaluate the utility of the Hisayama Score in stratifying cardiovascular risk among psoriasis patients.

Main Methods:

  • Retrospective analysis of 71 psoriasis patients (aged 40-79) without pre-existing comorbidities.
  • Stratification into low, moderate, and high cardiovascular risk groups based on blood pressure, lipids, and smoking history.
  • Application of the Hisayama Score to assess cardiovascular risk in relation to PASI scores.

Main Results:

  • Higher PASI scores were significantly associated with increased cardiovascular risk (p=0.003).
  • Male patients with PASI scores >10 were more often in moderate or high-risk groups (p=0.049).
  • Systolic blood pressure emerged as an independent predictor of cardiovascular risk.

Conclusions:

  • Psoriasis severity correlates with elevated cardiovascular risk, underscoring the need for proactive cardiovascular risk management in these patients.
  • The Hisayama Score is a useful tool for assessing cardiovascular risk in Japanese psoriasis patients.
  • Dermatologists should consider interdisciplinary approaches for managing cardiovascular risk in psoriasis patients.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
576
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
728
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
779
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
593